P.H.M. de Mulder

Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924

Cora N. Sternberg, P.H.M. de Mulder, Jan H. Schornagel et al. · Journal of Clinical Oncology · 2001 · 628 citations

Medicine, Oncology, Pharmacology +13

Equivalence of Three or Four Cycles of Bleomycin, Etoposide, and Cisplatin Chemotherapy and of a 3- or 5-Day Schedule in Good-Prognosis Germ Cell Cancer: A Randomized Study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council

Ronald de Wit, J.T. Roberts, P M Wilkinson et al. · Journal of Clinical Oncology · 2001 · 366 citations

Medicine, Oncology, Pharmacology +13

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

S. Krege, Rainer Souchon, Peter Albers et al. · European Urology · 2008 · 252 citations

Medicine, Cancer Biology, Oncology +17

Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and Vomiting

P.H.M. de Mulder · Annals of Internal Medicine · 1990 · 232 citations

Medicine, Oncology, Pharmacology +17

E‐cadherin expression in head and neck squamous‐cell carcinoma is associated with clinical outcome

Vera Mattijssen, P.H.M. de Mulder, H. M. Peters et al. · International Journal of Cancer · 1993 · 172 citations

Medicine, Oncology, Pathology +17